American Capital Advisory, LLC Recursion Pharmaceuticals, Inc. Transaction History

American Capital Advisory, LLC

  • $181 Billion
  • Q4 2024

A detailed history of American Capital Advisory, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, American Capital Advisory, LLC holds 200 shares of RXRX stock, worth $1,162. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Previous 200 -0.0%
Holding current value
$1,162
Previous $1.32 Million 2.58%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024
BUY
$7.35 - $10.05 $1,470 - $2,010
200 New
200 $1.97 Million
Q4 2023

Apr 09, 2024
BUY
$5.09 - $10.79 $1,018 - $2,158
200 New
200 $1.97 Million

About RECURSION PHARMACEUTICALS, INC.

RXRX Quotes by TradingView
  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.05B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track American Capital Advisory, LLC Portfolio

Follow American Capital Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Capital Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on American Capital Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email